Buspirone Hydrochloride

Product NDC
70518-3165
11-digit product format
705183165
Labeler code
70518
Product ID
70518-3165_c7939ac8-c5e1-bfd2-e053-2a95a90a393d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
buspirone hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA076008
Marketing category
ANDA
Marketing start
2021-07-20
Marketing end
0000-00-00
Substance
BUSPIRONE HYDROCHLORIDE
Active strength
8 mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3165-02023-03-20C16284748780-1f386c649-9ace-0266-e053-dadaa90a7c1a60c281d5-69f6-4be2-8faa-ca4aa0de3846
70518-3165-02023-01-30C16284748780-1f386c649-9ace-0266-e053-dadaa90a7c1a60c281d5-69f6-4be2-8faa-ca4aa0de3846

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3165-07051831650030 TABLET in 1 BLISTER PACK (70518-3165-0) 30 tablet2021-07-200000-00-00NoNoCurrent